Navigation Links
Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
Date:1/9/2008

MINNEAPOLIS, Jan. 9 /PRNewswire/ -- Nonin Medical, Inc.'s CEO, Gary Tschautscher received the highly regarded Industry Best Practices Award for CEO of 2007 for the North American Patient Monitoring Industry from Frost & Sullivan. Frost & Sullivan recognizes outstanding industry achievements in regional and global markets and the Awards are recognized worldwide by the media, the investment community and end-user markets. The global growth consulting company honored Tschautscher for his pioneering vision and strategic affiliations to bring Nonin's robust, portable and easy-to-use pulse oximetry technology to more people and applications worldwide.

"As a result of its strategic efforts in ongoing product innovation and support activities, Nonin has doubled its market share and achieved worldwide coverage, penetrating alternate care markets as well as leading the sleep diagnostic market," reported Frost and Sullivan. With well over 1 million oximeters sold worldwide, Nonin's oximeters have opened up a whole new direction in patient care in both acute care and alternate care markets. A number of Nonin's innovative "firsts" include the world's first self-contained fingertip oximeter, the first low power handheld oximeter and the first Bluetooth(R) Wireless Oximeter. Because of their accuracy, small size and portability,

Tschautscher and his management team have approached physiological monitoring with vigor, providing the most extensive line of pulse oximetry, capnography, software and sensors to both the human and veterinary markets. Tschautscher's boundless enthusiasm begins with his true care for the patient. "We are making a difference in how patients are cared for and that makes it all worthwhile. Our ultimate goal is to simplify patient monitoring and keep our focus on the future and how patient care is evolving."

About Nonin Medical, Inc. - http://www.nonin.com

Minneapolis-based Nonin Medical, Inc., a privately owned company specializing in the design and manufacture of physiological monitoring solutions, distributes its branded and 90+ OEM products to health and medical professionals in more than 125 countries. Since 1986, Nonin has developed a broad product line of pulse oximeters, capnographs, sensors, accessories and software for use by medical professionals. Its industry-leading capabilities in signal processing, sensor design and an innovative combination of features not available in competitive products are the foundation of its leadership in innovation.

About Frost & Sullivan - http://www.frost.com

Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com.


'/>"/>
SOURCE Nonin Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Noninvasive tests for cirrhosis may help to avoid liver biopsy
2. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
3. Nonin Medical is Honored With Niche Supplier Award from Amerinet
4. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
5. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
6. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
7. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
8. Medical, Behavioral Woes Can Drive Dogs to Bite
9. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
10. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
11. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ANN ARBOR, Mich. USA; SAN JOSE, Calif, USA; and SHANGHAI, ... ... (PRWEB) January 18, 2017 -- Global public ... pitcher to reduce arsenic V (pentavalent arsenic) to NSF/ANSI 53: ... Standard for drinking water treatment units. This certification verifies that ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Portee Insurance Agency, a family managed ... in central Maryland and the DC region, is inaugurating a charity event aimed at ... every year, making it the #1 killer in America. However, heart disease is largely ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. ... website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President ... the field of biosimilars through thought leader interaction in, live video and interactive ...
(Date:1/17/2017)... ... 17, 2017 , ... January is National Stalking Awareness Month (NSAM), now in its ... corners and commit the crime of stalking, a very real danger to many in our ... factor in stalking and other crimes. , “Stalking: know it. Name it. Stop it.”—so reads ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, ... Dr. Carol Francis re-releases powerfully uplifting interview with medical expert and prolific author, ... endure and pass through tough times, Dr. Bernie Siegel energizes listeners to live ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 Invetech, ... for cell and advanced therapies , has announced ... biopharmaceutical company developing "tumor starvation" treatments for acute ... needs. Under the agreement, Invetech will develop systems ... on Erytech,s proprietary ERYCAPS technology platform, which uses ...
(Date:1/18/2017)... -- After the recent election cycle, it is ... both for medical and recreational purposes are shifting. The evidence ... use of cannabis, but the focus is coming from both ... the North American legal cannabis market posted $6.7 billion in ... research projects sales will grow at a compound annual growth ...
(Date:1/17/2017)... , Jan. 17, 2017 North America Insulin ... new report, "North America Insulin Delivery Market Outlook to ... Insulin Delivery market. The report provides value, in millions ... (USD) within market segments - Insulin Pens, Insulin Pumps, ... report also provides company shares and distribution shares data ...
Breaking Medicine Technology: